Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 1.575 AUD 3.28% Market Closed
Market Cap: 425.5m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one IMR stock under the Base Case scenario is 0.836 AUD. Compared to the current market price of 1.575 AUD, Imricor Medical Systems Inc is Overvalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMR Relative Value
Base Case
0.836 AUD
Overvaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

289.5
P/S
P/S
Price to Sales
289.5
vs History
11
vs Industry
1
Median 3Y
88.5
Median 5Y
119
Industry
2.2
Forward
67.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.8
Industry
21.7
Forward
-18.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4
Median 5Y
-5.3
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-6
Industry
19.7
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
9
Median 3Y
-7.8
Median 5Y
2.5
Industry
2.1
More Details
293.8
EV/S
EV/S
Enterprise Value to Sales
293.8
vs History
3
vs Industry
1
Median 3Y
99.7
Median 5Y
120.1
Industry
2.3
Forward
68.1
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-46.5
Median 5Y
-46.5
Industry
4.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.2
Industry
11.4
Forward
-18.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-4.9
Industry
15.4
Forward
-18.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.6
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.4
Industry
17.2
More Details
50.5
EV/IC
EV/IC
Enterprise Value to IC
50.5
vs History
3
vs Industry
1
Median 3Y
10.8
Median 5Y
12.9
Industry
1.8
More Details

Multiples Across Competitors

IMR Competitors Multiples
Imricor Medical Systems Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Imricor Medical Systems Inc
ASX:IMR
425.5m AUD 289.5 -9.4 -18.3 -17.3
US
Abbott Laboratories
NYSE:ABT
230.9B USD 5.5 17.1 22.2 31.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.5B USD 22 77.3 62.4 75.8
US
Boston Scientific Corp
NYSE:BSX
154.4B USD 8.8 75.9 35.8 49.8
US
Stryker Corp
NYSE:SYK
149.2B USD 6.4 52.2 25.8 31
IE
Medtronic PLC
NYSE:MDT
110.5B USD 3.3 23.7 13.3 18.9
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 25.1 14.1 19.5
US
Becton Dickinson and Co
NYSE:BDX
48.6B USD 2.3 32 12.9 24
US
Edwards Lifesciences Corp
NYSE:EW
45.3B USD 8.2 10.8 24.8 27.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.6B USD 10.8 47.6 33.8 37.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
275.8B CNY 7.8 24.8 21.7 21.7

See Also

Summary
IMR intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMR stock valuation using valuation multiples.
Wall Street Estimates
IMR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 264,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.